Safety Strategies of Genetically Engineered T Cells in Cancer Immunotherapy

T-cell therapy using genetically engineered T cells modified with either T cell receptor or chi-meric antigen receptor holds great promise for cancer immunotherapy. The concerns about its toxicities still remain despite recent successes in clinical trials. Temporal and spatial control of the enginee...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Yan-Bei, Sun, Shang-Jun, Han, Shuang-Yin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876919/
https://www.ncbi.nlm.nih.gov/pubmed/29283058
http://dx.doi.org/10.2174/1381612824666171227222624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876919/
https://www.ncbi.nlm.nih.gov/pubmed/29283058
http://dx.doi.org/10.2174/1381612824666171227222624

Ejemplares similares